Novartis study of Afinitor® in advanced liver cancer does not meet primary endpoint of overall survival
Novartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival compared to placebo in...
Scientists discover potential new way to treat anxiety
Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, Vanderbilt University scientists will...
GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases
GlaxoSmithKline (GSK) has increased its commitment to the GAVI Alliance to provide vaccines to developing countries, helping to protect millions more children against infectious...
Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents
Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as possibly safer, more effective...
Studies suggest new key to ‘switching off’ hypertension
A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood...
New plan of attack in cancer fight
New research conducted by Harvard scientists is laying out a road map to one of the holy grails of modern medicine: a cure for...
Uncovering a healthier remedy for chronic pain
Physicians and patients who are wary of addiction to pain medication and opioids may soon have a healthier and more natural alternative. A Duke...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...



























